Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zaid Ahmed has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System)

    by Zaid Ahmed, Rashid Sayyid, Omid Yazdanpanah, Ravand Samaeekia, Arash Rezazadeh Kalebasty, David I. Lee, Mohammed Shahait

    Therapeutic options for advanced prostate cancer have expanded in recent years, incorporating multiple-system treatment approaches with differing mechanisms of action. However, comparative real-world safety data following drug approval remain limited. As such, the aim of this study is to characterize adverse events and disproportionate safety signals among advanced prostate cancer therapies using the FDA Adverse Event Reporting System (FAERS). A retrospective pharmacovigilance study of FAERS reports evaluated enzalutamide, darolutamide, apalutamide, abiraterone acetate, relugolix, niraparib/abiraterone, talazoparib, rucaparib, cabazitaxel, sipuleucel-T, and lutetium-177 vipivotide. Adverse events were categorized by System Organ Class and Preferred Terms. Reporting odds ratios (RORs) with 95% confidence intervals identified safety signals. Among 172,440 reports, most involved patients aged 65–85 years. Cabazitaxel had the highest proportion of serious reports (86.6%) and deaths (22%), whereas relugolix had the lowest (23.3% and 4.8%). Nervous system disorders predominated with enzalutamide and darolutamide, gastrointestinal disorders with abiraterone, rucaparib, and niraparib/abiraterone, and hematologic toxicities with cabazitaxel, talazoparib, and lutetium-177 vipivotide. Significant safety signals were identified for abiraterone and cabazitaxel, but not other therapies. The absence of a detected signal should not be interpreted as evidence of safety or equivalence, as reporting volume, detection bias, and statistical power varied across therapies. Overall, the therapies demonstrated distinct toxicity profiles, which may inform treatment selection, toxicity monitoring, and patient counseling.


  • Open Access

    Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-blockers vs 5-alpha Reductase Inhibitors

    by Zaid Ahmed, Elia Abou Chawareb, Muhammed A.M. Hammad, Samet Senel, Yara Matar, Jake Miller, Mohammed Shahait, Faysal A. Yafi


  • Open Access

    Access without approval: state-level determinants of peptide availability in sexual medicine

    by Sophia G Quesada, Zaid Ahmed, Hana S Nakamura, Yash H Kadakia, Elia Abou Chawareb, Muhammed A M Hammad, Juan J Andino, T Mike Hsieh, Jesse N Mills, Faysal A Yafi

    Background: Despite increasing use of peptides in sexual medicine, interstate differences in access are not fully explained by federal approval status and may instead reflect variation in state-level healthcare delivery structures. Aim: To systematically compare state-level environments affecting access to peptide-based sexual medicine therapies using objective proxy measures and to generate a clinician-friendly framework for identifying geographic disparities. Methods: We conducted a cross-sectional, state-level analysis of all 50 U.S. states and the District of Columbia. Access environments were characterized using three reproducible proxy variables reflecting clinical feasibility of care: (1) telehealth prescribing permissiveness, (2) nurse practitioner (NP) practice authority, and (3) availability of FDA-registered 503B outsourcing facilities normalized by population. Each variable was coded on a standardized scale and averaged to generate a compositive Peptide Access Environment Score (PAES). States were stratified into high-, moderate-, and low-access tiers. Regional differences were evaluated using nonparametric statistical testing and geographic visualization. Outcomes: Primary outcomes included state-level PAES values and access tier classification. Secondary outcomes included regional variation and concordance between telehealth regulation and compounding infrastructure. Results: PAES values ranged from 0.33 to 1.56, demonstrating substantial interstate variability. High-access environments clustered predominantly in the Northeast and West, while low-access states were most frequently observed in the South and parts of the Midwest. Regional differences in PAES were statistically significant (p < .001). Discordance between telehealth prescribing permissiveness and compounding infrastructure was identified, with multiple states permitting telehealth initiation of care despite lacking in-state 503B facilities, and others possessing compounding capacity but maintaining restrictive telehealth regulations. Clinical implications: State-level healthcare delivery policies and infrastructure may meaningfully influence patient access to peptide-based sexual medicine therapies independent of peptide-specific regulatory status. Strengths and limitations: Strengths include a transparent, reproducible methodology using publicly available data and a clinically grounded, multidimensional access framework. Limitations include reliance on proxy measures, exclusion of physician assistant autonomy, and inability to assess within-state socioeconomic or urban–rural heterogeneity. Conclusion: Interstate differences in telemedicine permissiveness, NP practice authority, and compounding infrastructure are associated with significant geographic disparities in access to peptide-based sexual medicine therapies in the United States.

  • Open Access

    The hidden barrier in men’s health: readability of online men’s health resources

    by Zaid Ahmed, Olivia F Madalone, Elia Abou Chawareb, Muhammed A M Hammad, Jake Miller, Gustavo Gryzinski, Mohammed Mahdi, Faysal A Yafi

  • Open Access

    Impact of Dobbs v. Jackson on Public Interest in Alternative Reproductive Procedures: Insights From Google Trends

    by Zaid Ahmed, Muhammed A. Moukhtar Hammad, Elia Abou Chawareb, Gustavo Gryzinski, Faysal A. Yafi, Jessica Yih

    Dobbs v. Jackson Women's Health Organization was one of the most pivotal cases regarding reproductive health and women's rights in recent history. The case resulted in the removal of the constitutional right to abortion for women across the United States. This study analyzes how the case influenced Google search trends for widely searched reproductive health terms. Google search volumes for five popular reproductive surgeries were collected between June 2020 and June 2024, 2 years before and after the overruling of Roe v. Wade on June 24, 2022. The search terms included were “salpingectomy,” “vasectomy,” “tubal ligation,” “vasectomy reversal,” and “hysterectomy.” Google search trends provided data for each of the terms on a scale from 0 to 100. The terms were then compared in terms of popularity to determine which procedure was most popular in relation to the case. Significant spikes in interest were found for all the search terms in response to the decision. In general, searches for hysterectomy ( R 2 = 0.3658) had the greatest interest, followed by vasectomy ( R 2 = 0.1722). The remaining terms had minimal interest in comparison, with tubal ligation ( R 2 = 0.0314), vasectomy reversal ( R 2 = 0.037), and salpingectomy ( R 2 = 0.7034) following in order of greatest to least interest. The findings highlight the significant impact the Dobbs v. Jackson Women's Health Organization decision had on public interest in reproductive procedures. These insights show how judicial rulings, legislative changes, and media coverage shape public interest in reproductive health across the United States.

  • Open Access

    It Can Only Get Worse: An Analysis of Factors Impacting Online Physician Reviews

    by Zaid Ahmed, Jake Miller, Muhammed A. Moukhtar Hammad, Gustavo Gryzinski, Elia Abou Chawareb, Faysal A. Yafi

    Physician review websites offer patients insight into their potential care teams when seeking a new provider. A firm understanding of the factors which patients deem important when assigning these ratings may allow sexual medicine providers an opportunity to improve patient satisfaction. Online ratings and reviews through Healthgrades.com and Vitals.com were collected for all physicians listed in the SMSNA healthcare provider directory. Physicians were included if they had received more than 10 ratings and 5 written reviews. The frequency for which specific positive and negative descriptors were included in written reviews compared to a provider's average online rating using Wilcoxon‐Mann‐Whitney tests and non parametric correlation. Factors which were significantly associated with changes on average ratings were then tested using multiple regression. Of 331 SMSNA providers, 145 (43.8%) met the inclusion criteria, including 129 male and 16 female providers, receiving an average of 57.0 ratings and 22.6 written reviews each. The average rating was 3.96/5. Factors signficantly associated with worsened online ratings included physicians appearing rude or uncaring (‒47.0%, p = 0.013), poor clinic staff or nurse quality (−39.2%, p = 0.000), lack of email or phone availability (−37.2%, p = 0.001), poor facilities appearance (−29.5%, p = 0.045), and complications following procedures (−22.7%, p = 0.028). No factors were significantly associated with improved ratings. Physicians can gain insight into the patient's perspective through a careful review of common trends in online physician reviews. On an analysis of reviews for SMSNA providers, multiple factors which remain in the provider's control, including availability, quality of explanations, appearing rushed, ability to answer questions, listening skills, medical knowledge, friendliness, trustworthiness, and patience. By focusing on these factors, sexual medicine providers may be able to maintain positive online reviews while offsetting the impact of factors that may remain outside their control, including the quality of clinic or hospital facilities and complications following procedures.

  • Open Access

    Epidemiological Insights into Erectile Dysfunction in the United States: A Google Trends Analysis

    by Zaid Ahmed, Muhammed A. Moukhtar Hammad, Jake Miller, Elia Abou Chawareb, Lawrence C. Jenkins, Faysal A. Yafi

    Background/Objectives: Erectile dysfunction (ED) significantly impacts the well-being and quality of life of millions of men. Understanding geographic patterns and associated factors influencing ED search trends can offer valuable insights for healthcare improvement and advocacy. This study investigated the correlation between Google search trends for ED and various factors across the US. Methods: Google search trends for “erectile dysfunction” were collected over a 6-year period between March 2018 and August 2024. The Google search trends provided data for individual states on a scale from 1 to 100. Search volumes were analyzed alongside the urologist-to-population ratio, percentage of the population aged 65 and older, median household income, and percentage of state residents with a bachelor’s degree or higher. Pearson correlation coefficients were used to examine the relationships between ED search volumes and these factors. Results: Higher ED search volumes were associated with a higher percentage of older adults (r = 0.4332, p = 0.001676). A negative correlation was found between ED search volume and higher education (r = −0.482, p = 0.000394). No significant correlation was found between median household income and ED search volume (r = −0.201, p = 0.164) or a greater urologist density (r = 0.0612, p = 0.6729). Conclusions: This study highlights how healthcare access and demographics influence ED search trends. States with older, less educated populations showed higher interest, while wealthier areas with more urologists had no significant correlation. These findings can guide targeted interventions to improve sexual care in underserved regions.